These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25875600)

  • 1. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141.
    Hsu JL; van den Boomen DJ; Tomasec P; Weekes MP; Antrobus R; Stanton RJ; Ruckova E; Sugrue D; Wilkie GS; Davison AJ; Wilkinson GW; Lehner PJ
    PLoS Pathog; 2015 Apr; 11(4):e1004811. PubMed ID: 25875600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the ERAD ubiquitin E3 ligases for viral and cellular targeting of MHC class I.
    van den Boomen DJ; Lehner PJ
    Mol Immunol; 2015 Dec; 68(2 Pt A):106-11. PubMed ID: 26210183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11.
    Pande NT; Powers C; Ahn K; Früh K
    J Virol; 2005 May; 79(9):5786-98. PubMed ID: 15827193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the MHC class II antigen presentation pathway by human cytomegalovirus.
    Johnson DC; Hegde NR
    Curr Top Microbiol Immunol; 2002; 269():101-15. PubMed ID: 12224504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
    Oresic K; Ng CL; Tortorella D
    J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties.
    Chevalier MS; Johnson DC
    J Virol; 2003 Apr; 77(8):4731-8. PubMed ID: 12663780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Macrophages Escape Inhibition of Major Histocompatibility Complex-Dependent Antigen Presentation by Cytomegalovirus and Drive Proliferation and Activation of Memory CD4
    Frascaroli G; Lecher C; Varani S; Setz C; van der Merwe J; Brune W; Mertens T
    Front Immunol; 2018; 9():1129. PubMed ID: 29887865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules.
    Furman MH; Ploegh HL; Tortorella D
    J Biol Chem; 2002 Feb; 277(5):3258-67. PubMed ID: 11717308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCMV US2 co-opts TRC8 to degrade the endoplasmic reticulum-resident protein LMAN2L.
    Hunter LM; Kite J; Fletcher-Etherington A; Nightingale K; Nobre L; Antrobus R; Fielding CA; Stanton RJ; Weekes MP
    J Gen Virol; 2024 Apr; 105(4):. PubMed ID: 38687323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus-encoded immune modulators partner to downregulate major histocompatibility complex class I molecules.
    Noriega VM; Tortorella D
    J Virol; 2009 Feb; 83(3):1359-67. PubMed ID: 19004944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity.
    Han J; Rho SB; Lee JY; Bae J; Park SH; Lee SJ; Lee SY; Ahn C; Kim JY; Chun T
    Mol Cells; 2013 Nov; 36(5):455-64. PubMed ID: 24213674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.
    Barel MT; Hassink GC; van Voorden S; Wiertz EJ
    Mol Immunol; 2006 Mar; 43(8):1258-66. PubMed ID: 16098592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation.
    Park B; Spooner E; Houser BL; Strominger JL; Ploegh HL
    J Exp Med; 2010 Aug; 207(9):2033-41. PubMed ID: 20713594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation.
    Chevalier MS; Daniels GM; Johnson DC
    J Virol; 2002 Aug; 76(16):8265-75. PubMed ID: 12134032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human CD1d molecules are resistant to human cytomegalovirus US2- and US11-mediated degradation.
    Cho S; Jun Y
    Biochem Biophys Res Commun; 2011 Oct; 413(4):616-22. PubMed ID: 21925141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules.
    Oresic K; Tortorella D
    J Gen Virol; 2008 May; 89(Pt 5):1122-1130. PubMed ID: 18420789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
    Noriega VM; Hesse J; Gardner TJ; Besold K; Plachter B; Tortorella D
    Mol Immunol; 2012 Jun; 51(2):245-53. PubMed ID: 22497807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells.
    Rehm A; Engelsberg A; Tortorella D; Körner IJ; Lehmann I; Ploegh HL; Höpken UE
    J Virol; 2002 May; 76(10):5043-50. PubMed ID: 11967320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.